Levetiracetam Actavis 250 mg
As listed in the register: Levetiracetam Actavis 250 mg, filmomhulde tabletten
250 mg · filmomhulde tablet
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Levetiracetam
- Made by
- Actavis Group PTC ehf
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Levetiracetam). It describes the substance, not this exact product.
The precise mechanism(s) by which levetiracetam exerts its antiepileptic effect is unknown.
A saturable and stereoselective neuronal binding site in rat brain tissue has been described for levetiracetam.
Levetiracetam is not extensively metabolized in humans.
Levetiracetam is eliminated from the systemic circulation by renal excretion as unchanged drug which represents 66% of administered dose.
Food does not affect the extent of absorption of levetiracetam but it decreases C max by 20% and delays T max by 1.5 hours.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-04
Safety of the active substance
From the US prescribing label for the same active substance (Levetiracetam). It describes the substance, not this exact product.
- Levetiracetam tablets are contraindicated in patients with a hypersensitivity to levetiracetam.
- Reactions have included anaphylaxis and angioedema [see Warnings and Precautions (5.4) ].
- Known hypersensitivity to levetiracetam; angioedema and anaphylaxis have occurred ( 4, 5.4 )
Most common adverse reactions (incidence ≥ 5% more than placebo) include:.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States36 matching products
European UnionNo exact match for this strength and form
Spain31 matching products
- KEPPRA 250 mg · comprimido recubierto con película3 makers
- EVEXIBAM 250 mg · comprimido recubierto con película
- LAURAK 250 mg · comprimido recubierto con película
- LEVETIRACETAM ACCORD 250 mg levetiracetam · comprimido recubierto con película
- LEVETIRACETAM ACTAVIS 250 mg levetiracetam · comprimido recubierto con película
- LEVETIRACETAM ALTER 250 mg · comprimido recubierto con película
- LEVETIRACETAM ARISTO 250 mg · comprimido recubierto con película
- LEVETIRACETAM ARISTOGEN 250 mg · comprimido recubierto con película
Canada20 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Actavis Group PTC ehf |
|---|---|
| Active substance | Levetiracetam |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 250 mg |
| Form | filmomhulde tablet |
| Classification | N03AX14 · Pain, sleep, mood, epilepsy and the brain |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Levetiracetam Actavis 250 mg, filmomhulde tabletten |
| RVG | EU/1/11/713 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.